Novo Holdings A/S - Q1 2022 holdings

Add to watchlist

$1.9 Billion is the total value of Novo Holdings A/S's 51 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 22.9% .

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
VTI SellVANGUARD INDEX FDStotal stk mkt$347,322,000
-25.6%
1,525,550
-21.1%
18.32%
-17.1%
BAM  BROOKFIELD ASSET MGMT INCcl a ltd vt sh$165,251,000
-6.3%
2,921,1710.0%8.72%
+4.4%
BSX  BOSTON SCIENTIFIC CORP$153,402,000
+4.3%
3,463,5770.0%8.09%
+16.1%
ASML NewASML HOLDING N V$143,671,000–215,099
+100.0%
7.58%–
CTLT NewCATALENT INC$141,032,000–1,271,707
+100.0%
7.44%–
AAPL SellAPPLE INC$106,666,000
-34.6%
610,879
-33.5%
5.63%
-27.2%
MORF SellMORPHIC HLDG INC$65,638,000
-32.4%
1,634,811
-20.3%
3.46%
-24.7%
CRM NewSALESFORCE.COM, INC.$63,484,000–299,000
+100.0%
3.35%–
NewARCELLX, INC.$56,317,000–4,016,878
+100.0%
2.97%–
BABA  ALIBABA GROUP HLDG LTDsponsored ads$54,490,000
-8.4%
500,8270.0%2.87%
+2.0%
EWTX  EDGEWISE THERAPEUTICS INC$54,196,000
-36.5%
5,587,2070.0%2.86%
-29.3%
MIRM SellMIRUM PHARMACEUTICALS INC$48,444,000
+24.2%
2,200,000
-10.0%
2.56%
+38.3%
TSM NewTAIWAN SEMICONDUCTOR MFG LTDsponsored ads$47,832,000–458,780
+100.0%
2.52%–
INGN  INOGEN INC$34,778,000
-4.6%
1,072,7350.0%1.84%
+6.3%
NKTX SellNKARTA INC$31,794,000
-25.9%
2,793,863
-0.0%
1.68%
-17.4%
FOLD  AMICUS THERAPEUTICS INC$24,245,000
-18.0%
2,560,2110.0%1.28%
-8.6%
CABO  CABLE ONE INC$23,242,000
-17.0%
15,8730.0%1.23%
-7.5%
CYT  CYTEIR THERAPEUTICS INC$18,248,000
-66.8%
4,840,4130.0%0.96%
-63.0%
 IO BIOTECH INC$17,373,000
-17.2%
3,277,9320.0%0.92%
-7.8%
VERV BuyVERVE THERAPEUTICS INC$17,115,000
-33.7%
750,000
+7.1%
0.90%
-26.1%
INSM BuyINSMED INC$16,587,000
-12.5%
705,838
+1.4%
0.88%
-2.6%
MIST SellMILESTONE PHARMACEUTICALS IN$16,243,000
-2.0%
2,530,003
-0.0%
0.86%
+9.2%
VECT SellVECTIVBIO HLDG AG$15,922,000
-7.9%
3,380,402
-4.0%
0.84%
+2.6%
LVTX  LAVA THERAPEUTICS NV$14,640,000
-20.0%
3,327,3120.0%0.77%
-10.9%
BPMC BuyBLUEPRINT MEDICINES CORP$14,534,000
-31.1%
227,526
+15.5%
0.77%
-23.2%
IOVA  IOVANCE BIOTHERAPEUTICS INC$13,928,000
-12.8%
836,5180.0%0.74%
-2.8%
BOLT  BOLT BIOTHERAPEUTICS INC$12,341,000
-44.1%
4,503,9910.0%0.65%
-37.7%
SILK BuySILK RD MED INC$11,399,000
+81.3%
276,068
+87.1%
0.60%
+101.7%
NARI BuyINARI MED INC$11,160,000
+69.3%
123,122
+70.5%
0.59%
+88.8%
INSP BuyINSPIRE MED SYS INC$10,639,000
+30.3%
41,448
+16.8%
0.56%
+45.0%
SPNE  SEASPINE HLDGS CORP$10,442,000
-10.7%
858,7520.0%0.55%
-0.5%
LUNG BuyPULMONX CORP$10,176,000
+28.4%
410,155
+66.0%
0.54%
+43.2%
RPHM  RENEO PHARMACEUTICALS INC$10,085,000
-65.6%
3,430,3770.0%0.53%
-61.7%
RCKT  ROCKET PHARMACEUTICALS INC$9,719,000
-27.4%
612,8220.0%0.51%
-19.0%
TMCI  TREACE MED CONCEPTS INC$9,463,000
+1.4%
500,4210.0%0.50%
+12.9%
PHVS  PHARVARIS N V$9,366,000
+26.1%
516,3210.0%0.49%
+40.3%
CRNX NewCRINETICS PHARMACEUTICALS IN$9,326,000–424,897
+100.0%
0.49%–
SellMINERVA SURGICAL INC$9,220,000
-12.8%
2,048,892
-0.4%
0.49%
-3.0%
SPRB  SPRUCE BIOSCIENCES INC$9,074,000
-54.9%
4,514,3360.0%0.48%
-49.7%
KNTE BuyKINNATE BIOPHARMA INC$7,029,000
-28.3%
624,236
+12.9%
0.37%
-20.0%
CMPI SellCHECKMATE PHARMACEUTICALS IN$6,897,000
+10.7%
2,161,990
-0.4%
0.36%
+23.4%
GRTX  GALERA THERAPEUTICS INC$5,852,000
-48.2%
2,459,0210.0%0.31%
-42.1%
GLTO  GALECTO INC$5,495,000
-27.4%
2,497,7910.0%0.29%
-19.0%
AKUS  AKOUOS INC$5,044,000
-44.1%
1,061,9900.0%0.27%
-37.7%
MQ  MARQETA INC$4,875,000
-35.7%
441,5580.0%0.26%
-28.4%
ALGS SellALIGOS THERAPEUTICS INC$4,193,000
-86.5%
1,950,000
-25.4%
0.22%
-85.0%
SPRO  SPERO THERAPEUTICS INC$4,079,000
-45.7%
468,9020.0%0.22%
-39.4%
ALNY  ALNYLAM PHARMACEUTICALS INC$4,082,000
-3.7%
25,0000.0%0.22%
+7.0%
VRNA  VERONA PHARMA PLCsponsored ads$3,798,000
-25.7%
761,2050.0%0.20%
-17.4%
NewRALLYBIO CORP$3,043,000–435,944
+100.0%
0.16%–
PRAX  PRAXIS PRECISION MEDICINES I$2,553,000
-48.2%
250,0000.0%0.14%
-42.1%
FRLN ExitFREELINE THERAPEUTICS HLDGSsponsored ads$0–-1,776,613
-100.0%
-0.17%–
AERI ExitAERIE PHARMACEUTICALS INC$0–-555,186
-100.0%
-0.18%–
ZGNX ExitZOGENIX INC$0–-442,550
-100.0%
-0.34%–
ExitEXSCIENTIA PLCads$0–-13,086,600
-100.0%
-12.24%–
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2022-05-27
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VANGUARD INDEX FDS41Q3 202264.7%
INOGEN INC34Q2 202268.8%
VANGUARD INTL EQUITY INDEX F29Q4 201637.6%
AMICUS THERAPEUTICS INC22Q3 20234.1%
AKEBIA THERAPEUTICS INC21Q3 20204.8%
VERONA PHARMA PLC21Q2 20221.9%
CORVUS PHARMACEUTICALS INC20Q4 20207.1%
INSPIRE MED SYS INC20Q3 20231.8%
CABLE ONE INC19Q3 20239.7%
FLEXION THERAPEUTICS INC19Q3 20214.7%

View Novo Holdings A/S's complete holdings history.

Latest significant ownerships (13-D/G)
Novo Holdings A/S Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cyteir Therapeutics, Inc.August 03, 20231,547,1364.4%
Disc Medicine, Inc.June 28, 20231,090,7724.8%
Galera Therapeutics, Inc.June 28, 20232,100,0004.9%
VectivBio Holding AGSold outMay 26, 202300.0%
LanzaTech Global, Inc.February 17, 202315,814,8458.1%
Bolt Biotherapeutics, Inc.Sold outJanuary 04, 202300.0%
Arcellx, Inc.December 12, 20221,750,0004.0%
MINERVA SURGICAL INCNovember 03, 20221,322,4734.5%
Milestone Pharmaceuticals Inc.October 24, 20221,378,5384.6%
Galecto, Inc.September 30, 20222,497,7919.8%

View Novo Holdings A/S's complete significant-ownership history.

Latest filings
TypeFiled
SC 13D/A2024-03-28
42024-03-25
SC 13D/A2024-03-25
42024-03-20
SC 13D/A2024-03-20
1442024-03-18
42024-03-18
SC 13D/A2024-03-18
1442024-03-14
SC 13D/A2024-03-07

View Novo Holdings A/S's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (1895745000.0 != 1895744000.0)
  • The reported has been restated
  • The reported has been amended

Export Novo Holdings A/S's holdings

CSVXLS